Pimstone Simon N.'s Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Mar 8, 2022
- Accession no.
- 0001209191-22-017341
- Filed
- Mar 8, 2022
- Trade date
- Mar 4-8, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 19 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.61M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001209191-22-017418 (Mar 8, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pimstone Simon N.CIK 0001620084 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | Common Shares | MOption exerciseAcquired | +10,288 | $3.67 | +$37,756.96 | 220,474 | Direct | |
| Mar 4, 2022 | Common Shares | FTax withholdingDisposed | −963 | $31.42 | −$30,257.46 | 219,511 | Direct | |
| Mar 4, 2022 | Common Shares | SSaleDisposed | −4,532 | $30.66 | −$138,951.12 | 214,979 | Direct | |
| Mar 4, 2022 | Common Shares | SSaleDisposed | −4,793 | $30.56 | −$146,474.08 | 210,186 | Direct | |
| Mar 7, 2022 | Common Shares | MOption exerciseAcquired | +20,576 | $3.67 | +$75,513.92 | 230,762 | Direct | |
| Mar 7, 2022 | Common Shares | FTax withholdingDisposed | −1,990 | $30.23 | −$60,157.7 | 228,772 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −5,037 | $30.60 | −$154,132.2 | 223,735 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −4,517 | $30.49 | −$137,723.33 | 219,218 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −4,516 | $30.45 | −$137,512.2 | 214,702 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −4,516 | $30.44 | −$137,467.04 | 210,186 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −2,500 | $30.52 | −$76,300 | 207,686 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −7,500 | $30.50 | −$228,750 | 200,186 | Direct | |
| Mar 7, 2022 | Common Shares | SSaleDisposed | −2,500 | $30.55 | −$76,375 | 197,686 | Direct | |
| Mar 8, 2022 | Common Shares | SSaleDisposed | −2,051 | $30.60 | −$62,760.6 | 195,635 | Direct | |
| Mar 8, 2022 | Common Shares | SSaleDisposed | −2,500 | $3.80 | −$9,500 | 193,135 | Direct | |
| Mar 8, 2022 | Common Shares | SSaleDisposed | −2,500 | $30.10 | −$75,250 | 190,635 | Direct | |
| Mar 8, 2022 | Common Shares | SSaleDisposed | −2,500 | $30.20 | −$75,500 | 188,135 | Direct | |
| Mar 8, 2022 | Common Shares | SSaleDisposed | −2,500 | $30.55 | −$76,375 | 185,635 | Direct | |
| Mar 8, 2022 | Common Shares | SSaleDisposed | −2,500 | $30.50 | −$76,250 | 183,135 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | Common Shares | MOption exerciseDisposed | −10,288 | $0.00 | $0 | 0 | Direct | |
| Mar 7, 2022 | Common Shares | MOption exerciseDisposed | −20,576 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.